Last reviewed · How we verify
NCT05736354: MMABIC
Molecular Mechanisms Associated With Breast Implant Complications
trial in Breast Implant; Complications in 1,000 participants. Currently enrolling.
30 June 2028
Quick facts
| Lead sponsor | Indiana University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 3 January 2021 |
| Primary completion | 30 June 2028 |
| Estimated completion | 30 June 2028 |
| Sites | 3 locations across United States |
Conditions studied
- Breast Implant; Complications — all drugs for Breast Implant; Complications →
- Infection or Inflammation — all drugs for Infection or Inflammation →
Sponsor
Indiana University
Who can join
18 and older, female only, with Breast Implant; Complications or Infection or Inflammation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Bacterial biofilms cause implant failures, chronic inflammation, and immune polarization. The study investigates the possible role of bacterial biofilm as a factor in the etiology of Breast Implant Illness. Three patient cohorts will be studied (A) Subjects with breast implant with BII manifestations (B) Subjects with breast implants without BII manifestations (C) Subjects without breast implants who underwent breast surgery procedure. Blood, surgically discarded tissue, implants, and associated capsules will be collected through this protocol.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05736354
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Implant; Complications
Currently open trials in the same condition.
- NCT06414785 — Characterization of Capsule Inflammation in Patients Exposed to Silicone Breast Implants · recruiting
- NCT05899387 — Seroma of the Mammary Gland · NA · recruiting
- NCT05757778 — Split Chest Breast Neurotization · NA · active not recruiting
- NCT06274736 — Safety and Performance of Motiva® Sizers · recruiting
Other Indiana University trials
Trials by the same sponsor.
- NCT07470086 — The Role of Environmental Temperatures in Respiratory Control · NA · not yet recruiting
- NCT07470099 — The Role of Breathing Perception in Respiratory Control · NA · not yet recruiting
- NCT07179952 — Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) · Phase 2 · not yet recruiting
- NCT07070804 — Maternal Biomarkers and Environmental Contributors to Autism Spectrum Disorders in Children of First-time Mothers · not yet recruiting
- NCT07499583 — Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05736354 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Indiana University
- Last refreshed: 10 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05736354.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing